Gleason pattern 5 is frequently underdiagnosed on prostate needle-core biopsy

Urology

Volumn 79, Issue 1, 2012, Pages 178-181

  Al Hussain, Turki O ^a   Nagar, Michael S ^a   Epstein, Jonathan I ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; DIAGNOSTIC ERROR; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; PATHOLOGIST; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; SCORING SYSTEM;

BIOPSY, NEEDLE; DIAGNOSTIC ERRORS; FALSE NEGATIVE REACTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASM GRADING; NEOPLASM INVASIVENESS; PROGNOSIS; PROSTATECTOMY; PROSTATIC NEOPLASMS; REFERRAL AND CONSULTATION; REGISTRIES; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS;

EID: 84655176744     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2011.08.060     Document Type: Article

References (16)

1. K. Trpkov, J. Zhang, M. Chan Prostate cancer with tertiary Gleason pattern 5 in prostate needle biopsy: clinicopathologic findings and disease progression Am J Surg Pathol 33 2009 233 240
2. L. Cheng, D.D. Davidson, H. Lin Percentage of Gleason pattern 4 and 5 predicts survival after radical prostatectomy Cancer 110 2007 1967 1972 (Pubitemid 350036855)
3. W.C. Allsbrook Jr., K.A. Mangold, M.H. Johnson Interobserver reproducibility of Gleason grading of prostatic carcinoma: general pathologist Hum Pathol 32 2001 81 88 (Pubitemid 32150632)
4. J.I. Epstein, W.C. Allsbrook Jr., M.B. Amin The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma Am J Surg Pathol 29 2005 1228 1242 (Pubitemid 41232997)
5. D.F. Gleason Classification of prostatic carcinomas Cancer Chemother Rep 50 1966 125 128
6. D.F. Gleason, G.T. Mellinger Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging J Urol 111 1974 58 64
7. G.T. Mellinger Prognosis of prostatic carcinoma Recent Results Cancer Res 60 1977 61 72 (Pubitemid 8088386)
8. A.W. Partin, J. Yoo, H.B. Carter The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer J Urol 150 1993 110 114 (Pubitemid 23175983)
9. A.W. Partin, M.W. Kattan, E.N. Subong Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer A multi-institutional update JAMA 277 1997 1445 1451 (Pubitemid 27208886)
10. A.W. Partin, L.A. Mangold, D.M. Lamm Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium Urology 58 2001 843 848 (Pubitemid 34017254)
11. D.V. Makarov, B.J. Trock, E.B. Humphreys Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005 Urology 69 2007 1095 1101 (Pubitemid 46891611)
12. C.T. Nguyen, M.W. Kattan Development of a prostate cancer metagram: a solution to the dilemma of which prediction tool to use in patient counseling Cancer 115 2009 3039 3045
13. Fajardo DA, Miyamoto H, Miller J, et al. Identification of Gleason pattern 5 on prostatic needle core biopsy: frequency of underdiagnosis and relation to morphology. AJSP. In press.
14. A. Nanda, M.H. Chen, A.A. Renshaw Gleason pattern 5 prostate cancer: further stratification of patients with high-risk disease and implications for future randomized trials Int J Radiat Oncol Biol Phys 74 2009 1419 1423
15. A. Sabolch, F.Y. Feng, S. Daignault-Newton Gleason pattern 5 is the greatest risk factor for clinical failure and death from prostate cancer after dose-escalated radiation therapy and hormonal ablation Int J Radiat Oncol Biol Phys 2011
16. H. Mitsuyama, K. Wallner, G. Merrick The prognostic significance of Gleason pattern 5 in prostate cancer patients treated with Pd-103 brachytherapy Am J Clin Oncol 30 2007 597 600 (Pubitemid 350307184)